The magnitude and cross reactivity of SARS-CoV-2 specific antibody responses in vaccinated and unvaccinated Sri Lankan children and association with nutrition status ===================================================================================================================================================================== * Chandima Jeewandara * Maneshka Vindesh Karunananda * Suranga Fernando * Saubhagya Danasekara * Gamini Jayakody * S. Arulkumaran * N.Y. Samaraweera * Sarathchandra Kumarawansha * Subramaniyam Sivaganesh * P. Geethika Amarasinghe * Chintha Jayasinghe * Dilini Wijesekara * Manonath Bandara Marasinghe * Udari Mambulage * Helanka Wijayatilake * Kasun Senevirathne * A.D.P Bandara * C.P. Gallage * N.R. Colambage * A.A. Thilak Udayasiri * Tharaka Lokumarambage * Y. Upasena * W.P.K.P. Weerasooriya * seroprevalence study group * Tiong Kit Tan * Alain Townsend * Graham S. Ogg * Gathsaurie Neelika Malavige * Study groups * Lahiru Perera * Pradeep Pushpakumara * Laksiri Gomes * Jeewantha Jayamali * Inoka Sepali Aberathna * Thashmi Nimasha * Madushika Dissanayake * Shyrar Ramu * Deneshan Peranantharajah * Hashini Colambage * Rivindu Wickramanayake * Harshani Chathurangika * Farha Bary * Sathsara Yatiwelle * Michael Harvie * Maheli Deheragoda * Tibutius Jayadas * Shashini Ishara * Dinuka Ariyaratne * Shashika Dayarathna * Ruwanthi Wijekulasuriya * Chathura Ranathunga ## Abstract **Background** We investigated the seropositivity rates of Sri Lankan children in a large island wide serosurvey, to determine the magnitude and breadth of antibody responses to SARS-CoV-2 variants and the association with the vaccination and nutritional status to understand the likely impact of newer variants in Sri Lanka. **Methods** Using the WHO UNITY protocol, we recruited 5207 children, aged 10 to 20 years, representative of the 9 provinces of Sri Lanka, and assessed seropositive rates, ACE2 blocking antibodies and antibodies to BA.2.75 and XBB.1.5, in vaccinated and unvaccinated children. Anthropometric measurements were taken to determine the association between nutrition status and antibody levels. **Results** 3111/3119 (99.7%) vaccinated and 2008/2088 (96.2%) of unvaccinated children, were seropositive for SARS-CoV-2. 2984/3111 (95.9%) of vaccinated children had ACE2 blocking antibodies above the cut-off threshold, compared to 1346/2008 (67.0%) of unvaccinated children. 27.2 % unvaccinated children had positive antibody responses to BA.2.75 and 30.7% to XBB.1.5, while 64.3% of vaccinated had a positive response to BA.2.75 and 43.1% to XBB.1.5. Vaccinated children had significantly higher titres of total antibodies, ACE2 blocking antibodies and antibodies to XBB.1.5 and BA.2.75 than unvaccinated children. However, the vaccinated had significantly higher responses to BA.2.75 (p<0.0001), than XBB.1.5. Unvaccinated children, with <3rd BMI centile had significantly lower ACE2 blocking antibodies than other groups. **Discussion** The high seropositivity rates and antibody titres to SARS-CoV-2 variants in unvaccinated children, suggests that they are likely to have been infected more than once with SARS-CoV-2. The implications of lower antibody levels in undernourished children should be further investigated. ## Background Despite high vaccination rates and high seroprevalence rates in many countries, outbreaks of COVID-19 still occur in many regions, with the XBB.1.5 sub-lineages of omicron EG.5.1, XBB.2.3 and XBB.1.16 dominating [1, 2]. Although the number of hospital admissions and case fatality rates are low, COVID-19 still causes a significant impact on health care systems in some countries [1]. Many high-income countries and some lower-middle income countries are administering booster doses to their populations with updated versions of the COVID-19 vaccines, incorporating the XBB.1.5 variant [3]. While many countries are making these updated COVID-19 booster doses only available to vulnerable individuals, the CDC in USA has recommended these vaccines to all individual above the age of six months [3]. Sri Lanka experienced many COVID-19 outbreaks in the past, with high mortality rates, especially during the outbreak due to the delta variant [4]. However, deaths have been predominantly among the adults, with children rarely developing severe disease, as seen in all other countries [5, 6]. Although 28.5% of the population in Sri Lanka are children (<18 years of age), they accounted for <18% of reported cases of COVID-19, possibly due to the asymptomatic nature of infection among children [7, 8]. Therefore, the reported number of cases are unlikely to reflect true infection rates among children and seroprevalence studies are required to understand the true infection rates in the population. Furthermore, unlike many other countries globally and in the region, Sri Lanka did not offer any bivalent booster doses for individuals in Sri Lanka and children >12 years of age were offered only two doses of the Pfizer BioNTech (BNT162b2) vaccine. Therefore, the Sri Lankan population were expected to be vulnerable to the sub-lineages of the omicron variant, especially the XBB.1.5 and its sub lineages, which are very immune evasive [9]. The nutritional status affects immunity to many viral infections, and the intake of micro and macronutrients has shown to affect susceptibility to SARS-CoV-2 infection [10]. Obesity has shown to be associated with a significantly lower antibody responses to COVID-19 vaccines [11, 12]. However, there are limited data on antibody responses to SARS-CoV-2 following natural infection or vaccination in those who are underweight or malnourished. As Sri Lanka is going through an economic crisis, it has been estimated that 28.2% of the population are below the poverty line ( 99.4% of vaccinated children were seropositive in all districts, >94.25% of unvaccinated children were also seropositive in all districts. Therefore, overall, in Sri Lanka, irrespective of vaccination status, >94.25% of children were seropositive for SARS-CoV-2, with seropositivity rates reaching > 97% in four districts. There was no difference in the seropositivity rates in unvaccinated children in urban (97.5%), rural (95.8%) and estate (96.2%), showing that children in all areas in Sri Lanka were equally infected with the SARS-CoV-2 virus. View this table: [Table 1:](http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300176/T1) Table 1: The number of children recruited from each district from Sri Lanka, with seropositivity rates in vaccinated and unvaccinated children measured by the Wantai total antibody assay The number of children recruited from each district and seropositivity rates in vaccinated and unvaccinated children are shown in supplementary tables 1 to 9. ### Differences in ACE2 blocking antibody titres in vaccinated and unvaccinated children 2984/3111 (95.9%) children who had received at least one dose of the vaccine had ACE2 blocking antibodies above the cut-off threshold of a positive response (>25% inhibition), compared to 1346/2008 (67.0%) of unvaccinated children. The positivity rates for ACE2 blocking antibodies of vaccinated children from all districts was >91.4%, with positivity rates being >96% in five districts (Table 2). Unvaccinated children (median 67.6%, IQR 16.8 to 97.3 % of inhibition) had significantly lower (p<0.0001) titres than vaccinated children (median 98.7, IQR 91.9 to 99.2 % of inhibition). Interestingly, the ACE2 blocking antibody positivity rates and antibody titres were higher in some districts compared to others, among unvaccinated children (Table 2, Figure 1A and B). For instance, unvaccinated children in Jaffna had a median ACE2 blocking antibody titres of 91.1 (IQR 48.6 to 98.7% of inhibition). The ACE2 blocking antibody titres in vaccinated children were also highest in the Jaffna district followed by the Trinco district. ![Figure 1:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/12/19/2023.12.18.23300176/F1.medium.gif) [Figure 1:](http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300176/F1) Figure 1: ACE2 blocking antibody levels determined by the surrogate SARS-CoV-2 neutralising antibody assay (sVNT) in vaccinated and unvaccinated children of different districts in Sri Lanka. The ACE2 blocking antibody levels (% of inhibition) were measured in vaccinated (A, n=3111) and unvaccinated (B, n=2008) children between the ages of 10-20 years of age in nine districts in Sri Lanka. The Mann-Whitney U test (two tailed) was used to calculate the differences in the means in the ACE2 antibody titres in different districts in vaccinated and unvaccinated children. All tests were two sided. Data are presented as median values +/- interquartile ranges as appropriate. View this table: [Table 2:](http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300176/T2) Table 2: The number of children tested for ACE2 blocking antibodies from each district in Sri Lanka, with seropositivity rates in vaccinated and unvaccinated children The positivity rates for ACE2 blocking antibodies were significantly higher in unvaccinated children in urban (291/391, 74.4%, p=0.0016) and estate areas (37/48, 77.1%, p=0.004), compared to children living in rural areas (1018/1569, 64.9%). However, there was no association with the population density and ACE2 blocking antibody levels in each district (Spearmans’ R=0.15, p=0.69). The positivity rates for ACE2 blocking antibodies in vaccinated and unvaccinated children are shown in supplementary tables 10 to 18. ### Antibody responses to SARS-CoV-2 omicron variants in vaccinated and unvaccinated children We carried out HAT assays to assess antibody responses to BA.2.75 and XBB.1.5 in samples of 10% of the unvaccinated seropositive children, which were randomly selected representative of all the nine districts (n=202). These assays were carried out in a similar number (n=202) of vaccinated children representative of all nine districts in Sri Lanka. 130/202 (64.3%) vaccinated and 55 (27.2 %) unvaccinated children had an antibody titre of ≥ 1:40 to BA.2.75. For XBB.1.5, 87 (43.1%) vaccinated and 62 (30.7%) unvaccinated children had an antibody titre of ≥ 1:40. The vaccinated children had significantly higher antibody titres to both XBB.1.5 (p=0.01) and BA.2.75 (p<0.0001), although this difference was more significant for BA.2.75 (Figure 2). In vaccinees, the antibody titres were significantly higher to BA.2.75 than to XBB.1.5 (p<0.0001) whereas there was no difference in antibody titres to these variants in unvaccinated children (p=0.18) (Figure 2). Therefore, the vaccinated children were significantly more likely to have a positive response of ≥ 1:40 to BA.2.75 (odds ratio 2.4, 95% CI 1.6 to 3.6, p<0.0001) compared to XBB.1.5. In fact, 59 (29.2%) of vaccinated children had a titre of ≥ 1:80 to BA.2.75 compared to 35 (17.3%) to XBB.1.5. ![Figure 2:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/12/19/2023.12.18.23300176/F2.medium.gif) [Figure 2:](http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300176/F2) Figure 2: Antibody responses to the omicron sub-lineages XBB.1.5 and BA.2.75 in vaccinated and unvaccinated children in Sri Lanka. The hemagglutination test was carried out to determine antibody responses to XBB.1.5 and BA.2.75 in vaccinated (n=202) and unvaccinated (n=202) representative of all nine districts of Sri Lanka, at 1:40 and 1:80 dilutions, as previously described. The Wilcoxon matched pairs signed rank test was used to compare the means of the HAT titres for the XBB.1.5 and BA.2.75 in the same individuals. The Mann-Whitney U test (two tailed) was used to calculate the differences in the means in the HAT titres in the vaccinated and unvaccinated children. All tests were two sided. Data are presented as median values +/- interquartile ranges as appropriate. ### The magnitude of antibody responses to SARS-CoV-2 based on nutritional status As previously described by us [28], in this island wide large cohort of children, 4782/5207, were children between the ages of 10 to 18, and the BMI centile was determined to find out their nutritional status. In this cohort of children (n=4782), 1057 (22.1%) had a BMIs <3rd centile for age, and therefore were classified as underweight. 215 (4.5%) children had a BMI of >97th centile for age, when plotted on the WHO BMI for age charts and were considered severely overweight. Among the unvaccinated children, those who had a BMI of <3rd centile had significantly lower ACE blocking antibodies (median 51.9, IQR 13.1 to 95.5 % of inhibition), which is a surrogate marker for the presence of Nabs compared to children of other categories (Figure 3A). Children with a BMI centile between 85th to 97th had the higher titres of ACE2 blocking antibodies (median 82.7, IQR 21.6 to 99.7, % of inhibition). Among vaccinated children the ACE2 blocking antibody titres were similar in children of different nutritional status (Figure 3B). ![Figure 3:](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2023/12/19/2023.12.18.23300176/F3.medium.gif) [Figure 3:](http://medrxiv.org/content/early/2023/12/19/2023.12.18.23300176/F3) Figure 3: ACE2 blocking antibody levels determined by the surrogate SARS-CoV-2 neutralising antibody assay (sVNT) in vaccinated and unvaccinated children of different BMI centile categories. The ACE2 blocking antibody levels (% of inhibition) were measured in vaccinated (A, n=2723) and unvaccinated (B, n=1973) children between the ages of 10-18 years of age, of different BMI centiles for age. The Mann-Whitney U test (two tailed) was used to calculate the differences in the means in the ACE2 antibody titres in different BMI groups in the vaccinated and unvaccinated. All tests were two sided. Data are presented as median values +/- interquartile ranges as appropriate. ## Discussion In this study we carried out an island-wide serosurvey to determine the SARS-CoV-2 seropositivity rates among vaccinated and unvaccinated children, representing all the nine provinces in Sri Lanka. We found that the overall seropositivity rates of the unvaccinated children (96.2%) and vaccinated children (99.7%) were similar, indicating a high infection rate in all areas in Sri Lanka by March 2023. However, the titres of ACE2 blocking antibodies (surrogate marker for Nabs) and the levels of total antibodies to the RBD of the virus was significantly higher among vaccinated children, indicating vaccines provided a higher magnitude of antibodies compared to natural infection. Interestingly, the ACE2 antibody positivity rates and titres were significantly higher among unvaccinated children in some districts compared to others. We previously showed that in unvaccinated, naturally infected adults, many had low levels of ACE2 blocking antibodies (median levels, 22.3 % of inhibition), with only 50% having antibody levels above the positive cut-off threshold (>25% of inhibition) [21]. In this study, overall, 67.0% of unvaccinated children had ACE2 blocking antibody titres above the cut-off threshold and the median values were 67.6%, which were several folds higher than what we found in individuals who had one natural infection with SARS-Cov-2 in 2020 [21]. In some districts such as Jaffna the median values were 91.1, followed by 80.4 % of inhibition in the Trinco district, which are several folds higher than found in individuals following a single episode of natural infection. Therefore, given the high positivity rates for ACE2 blocking antibodies and high titres seen in unvaccinated children, it is likely that children (vaccinated and unvaccinated) are likely to have been infected more than once with SARS-CoV-2. We assessed antibody responses to omicron sub-lineages BA.2.75 and XBB.1.5 in the sub cohort of vaccinated and unvaccinated children. 64.3% of vaccinated and 27.2 % unvaccinated children had antibody titre above the positive cut off threshold to BA.2.75, and 43.1% of vaccinated and 30.7% unvaccinated children to XBB.1.5. Sri Lanka reported circulation of BA.2.75 variants during the latter part of 2022 [2], while the XBB variants were only found after the study recruitment had finished. Therefore, although the children could have experienced infection with BA.2.75, they are less likely to have been exposed to the variants of the XBB lineage. However, there was no difference in positivity rates or the antibody titres to BA.2.75 and XBB.1.5 in unvaccinated children, suggesting that previous infection in many induced a broader antibody response to other variants. Vaccinated children had higher positivity rates and higher antibody titres to both BA.2.75 and XBB.1.5 than unvaccinated children, showing that vaccination induced a broader antibody response of higher magnitude for many SARS-CoV-2 variants. Interestingly, the vaccinated children had significantly higher antibody responses to BA.2.75 than to XBB.1.5. As XBB.1.5 has many more mutations within the RBD than BA.2.75 [9], it is likely that it escapes vaccine induce immunity at a far greater extent than BA.2.75. Furthermore, many children received their vaccines during the BA.2 wave in Sri Lanka [2], it is likely they would have been exposed to the vaccine virus and BA.2 during a very short period, thereby inducing robust immune responses to BA.2 sub-lineages. Indeed, Sri Lanka has reported very few cases of COVID-19 in 2023, possibly due to limited testing carried out [8]. However, the number have deaths have also remained low, with 69 deaths reported for 2023, until 20th November 2023 [8]. Therefore, vaccination along with natural infection with omicron variants such as BA.2 and subsequently BA.4/BA.5, would have given the population a broader immune response, thereby reducing the impact of the newer omicron sub lineages of the XBB series, despite the non-availability of bi-valent or monovalent vaccines with omicron boosters. Sri Lanka is going through an economic crisis, with many children not having access to nutritious food [13]. Indeed, we found that 22.1% of children were <3rd BMI centile for age, indicating under nutrition. Although the seropositivity rates among different age groups did not differ, there were significant differences in ACE2 blocking antibody levels, which are surrogate markers of Nabs [18, 21]. Nabs antibodies prevent binding to the ACE2 receptor and have shown to associate with protection [29]. Children with undernutrition (<3rd BMI centile for age), had significantly lower ACE2 blocking antibody titres compared to children of healthy weight. There was no difference in the ACE2 blocking antibodies in children with undernutrition and obese children (>9th BMI centile for age), suggesting that those with a normal nutrition status, are likely to have a more robust antibody response. However, in this study we only investigated antibody responses to the spike protein using different types of assays and it would be important to understand the antibody responses to other proteins such as the N protein, which has also shown to associate with protection. Furthermore, although more recent SARS-CoV-2 omicron variants almost completely evade neutralization with antibodies specific to the earlier SARS-CoV-2 variants (Wuhan-Hu-1) [9], they do not completely evade T cell responses [30, 31]. Therefore, in order to fully understand the population immunity to SARS-CoV-2 variants, also in the context of the nutrition status, it would be important to assess the functionality, magnitude and the breadth of T and B cell responses to the virus. ## Funding statement This study has been supported by WHO Unity Studies, a global sero-epidemiological standardization initiative, with funding to WHO and the UK Medical Research Council. T.K.T. is funded by the Townsend-Jeantet Charitable Trust (charity number 1011770) and the EPA Cephalosporin Early Career Researcher Fund. A.T. are funded by the Chinese Academy of Medical Sciences (CAMS) Innovation Fund for Medical Science (CIFMS), China (grant no. 2018-I2M-2-002). ## Supporting information Supplementary tables [[supplements/300176_file05.docx]](pending:yes) ## Data Availability All data are available within the manuscript, figures and the tables. Individual data points are shown in all figures. * Received December 18, 2023. * Revision received December 18, 2023. * Accepted December 19, 2023. * © 2023, Posted by Cold Spring Harbor Laboratory This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/) ## References 1. 1.Hannah Ritchie EM, Lucas Rodés-Guirao, Cameron Appel, Charlie Giattino, Esteban Ortiz-Ospina, Joe Hasell, Bobbie Macdonald, Diana Beltekian and Max Roser (2020). Coronavirus Pandemic (COVID-19). 02/24/2022 ed, 2022. 2. 2.Hadfield J, Megill C, Bell SM, et al. Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 2018; 34:4121–3. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10/gdkbqx&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F19%2F2023.12.18.23300176.atom) 3. 3.Lenharo M. COVID boosters are back: what scientists say about whether to get one. Nature 2023; 621:449–50. 4. 4.Ranasinghe D, Jayathilaka D, Jeewandara C, et al. Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka. Front Public Health 2022; 10:873633. 5. 5.Tian W, Jiang W, Yao J, et al. Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis. Journal of medical virology 2020. 6. 6.Ledford H. Deaths from COVID ’incredibly rare’ among children. Nature 2021; 595:639. 7. 7.UNICEF. Sri Lanka: General country profile, 2022:1-3 8. 8. Epidemiology unit MoH, Sri Lanka. COVID-19 Epidemiology Sri Lanka, 2023:1-2. 9. 9.Carabelli AM, Peacock TP, Thorne LG, et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nature reviews 2023; 21:162–77. 10. 10.Deschasaux-Tanguy M, Srour B, Bourhis L, et al. Nutritional risk factors for SARS-CoV-2 infection: a prospective study within the NutriNet-Sante cohort. BMC Med 2021; 19:290. 11. 11.Ou X, Jiang J, Lin B, et al. Antibody responses to COVID-19 vaccination in people with obesity: A systematic review and meta-analysis. Influenza Other Respir Viruses 2023; 17:e13078. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/irv.13078&link_type=DOI) 12. 12.Kara Z, Akcin R, Demir AN, et al. Antibody Response to SARS-CoV-2 Vaccines in People with Severe Obesity. Obes Surg 2022; 32:2987–93. 13. 13.UNICEF. Sri Lanka: Country Office Annual Report 2022, 2022:1-9. 14. 14.Jeewandara C, Karunananda MV, Fernando S, et al. The burden of dengue and risk factors of transmission in nine districts in Sri Lanka. medRxiv 2023:2023.04.23.23288986. 15. 15.Bergeri I, Lewis HC, Subissi L, et al. Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic. Influenza Other Respir Viruses 2022; 16:7–13. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F19%2F2023.12.18.23300176.atom) 16. 16.Jeewandara C, Guruge D, Abyrathna IS, et al. Seroprevalence of SARS-CoV-2 Infection in the Colombo Municipality Region, Sri Lanka. Front Public Health 2021; 9:724398. 17. 17.Weidner L, Gansdorfer S, Unterweger S, et al. Quantification of SARS-CoV-2 antibodies with eight commercially available immunoassays. J Clin Virol 2020; 129:104540. 18. 18.Tan CW, Chia WN, Qin X, et al. A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction. Nature biotechnology 2020; 38:1073–8. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41587-020-0631-z&link_type=DOI) [PubMed](http://medrxiv.org/lookup/external-ref?access_num=http://www.n&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F19%2F2023.12.18.23300176.atom) 19. 19.Tan CW, Chia WN, Young BE, et al. Pan-Sarbecovirus Neutralizing Antibodies in BNT162b2-Immunized SARS-CoV-1 Survivors. The New England journal of medicine 2021; 385:1401–6. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/nejmoa2108453&link_type=DOI) 20. 20.Chia WN, Zhu F, Ong SWX, et al. Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study. Lancet Microbe 2021; 2:e240–e9. 21. 21.Jeewandara C, Jayathilaka D, Gomes L, et al. SARS-CoV-2 neutralizing antibodies in patients with varying severity of acute COVID-19 illness. Sci Rep 2021; 11:2062. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41598-021-81629-2&link_type=DOI) 22. 22.Townsend A, Rijal P, Xiao J, et al. A haemagglutination test for rapid detection of antibodies to SARS-CoV-2. Nature Communications 2020:2020.10.02.20205831. 23. 23.Ellis D, Brunette N, Crawford KHD, et al. Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design. Frontiers in immunology 2021; 12:710263. 24. 24.Jeewandara C, Kamaladasa A, Pushpakumara PD, et al. Immune responses to a single dose of the AZD1222/Covishield vaccine in health care workers. Nat Commun 2021; 12:4617. [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1038/s41467-021-24579-7&link_type=DOI) 25. 25.Ertesvag NU, Xiao J, Zhou F, et al. A rapid antibody screening haemagglutination test for predicting immunity to SARS-CoV-2 variants of concern. Commun Med (Lond) 2022; 2:36. 26. 26.Centre for Disease Control and Prevention U. About Child & Teen BMI. Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion: Division of Nutrition, Physical Activity, and Obesity, National Center for Chronic Disease Prevention and Health Promotion, 2021. 27. 27.Ezzat MA, Albassam EM, Aldajani EA, Alaskar RA, Devol EB. Implementation of new indicators of pediatric malnutrition and comparison to previous indicators. Int J Pediatr Adolesc Med 2022; 9:216–24. 28. 28.Jeewandara C, Karunananda MV, Fernando S, et al. Are the rise in childhood obesity rates leading an increase in hospitalizations due to dengue? medRxiv 2023:2023.09.14.23295528. 29. 29.Follmann D, O’Brien MP, Fintzi J, et al. Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration. Nat Commun 2023; 14:3605. 30. 30.Tarke A, Coelho CH, Zhang Z, et al. SARS-CoV-2 vaccination induces immunological T cell memory able to cross-recognize variants from Alpha to Omicron. Cell 2022; 185:847–59.e11. [PubMed](http://medrxiv.org/lookup/external-ref?access_num=35139340&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2023%2F12%2F19%2F2023.12.18.23300176.atom) 31. 31.Wang Q, Iketani S, Li Z, et al. Alarming antibody evasion properties of rising SARS-CoV-2 BQ and XBB subvariants. Cell 2023; 186:279–86.e8.